Vak MKNO is onderdeel van de premaster Klinische Gezondheidswetenschappen. Tentamen gehaald met een 7,6 mede door deze aantekeningen.
Disclaimer: dit document bevat niet 100% alle informatie, ik heb mijn best gedaan alles mee te typen tijdens het vak en alle onderdelen uit te werken. Er ontbreek...
,Inhoud
College 1 MKNO ...................................................................................................................................... 6
Deductief redeneren........................................................................................................................... 6
Inductief redeneren ............................................................................................................................ 6
Etiologisch onderzoek ......................................................................................................................... 6
Diagnostisch onderzoek ...................................................................................................................... 6
Interventie onderzoek ........................................................................................................................ 7
Klinimetrisch onderzoek ..................................................................................................................... 7
Algemene epidemiologische breuk: ................................................................................................... 7
College 2 MKNO ...................................................................................................................................... 9
Probleem- doel- en vraagstelling ........................................................................................................ 9
Probleemstelling ................................................................................................................................. 9
Doelstelling ......................................................................................................................................... 9
Ontwikkelfase van de onderzoeksvraag ............................................................................................. 9
Formuleren onderzoeksvraag, bestaat uit 2 stappen ....................................................................... 10
Definitie hypothese .......................................................................................................................... 11
Toetsen van hypothesen................................................................................................................... 11
Domein versus studiepopulatie ........................................................................................................ 12
Census ............................................................................................................................................... 13
Steekproef trekking – sampling ........................................................................................................ 13
Sampling technieken......................................................................................................................... 13
Epidemiologische functie à ............................................................................................................. 13
Selecte steekproeven........................................................................................................................ 14
Cohort VS dynamische populatie ...................................................................................................... 14
Voor- en nadelen cohortstudie ......................................................................................................... 15
Dynamische populatie ..................................................................................................................... 15
Case-control study ............................................................................................................................ 16
Voor- en nadelen case-control study ................................................................................................ 17
Generaliseerbaarheid – representativiteit ....................................................................................... 17
Aspecten in studie design ................................................................................................................. 17
Uitkomst en determinanten ............................................................................................................. 18
Beschrijvend vs. verklarend .............................................................................................................. 18
College 3 MKNO .................................................................................................................................... 19
Frequentie maten ............................................................................................................................. 20
Epidemiologische breuk incidentie/prevalentie ............................................................................... 20
Prevalentie ........................................................................................................................................ 20
2
, Punt-prevalentie ............................................................................................................................... 21
Periode-prevalentie .......................................................................................................................... 21
Incidentie .......................................................................................................................................... 21
Cumulatieve incidentie ..................................................................................................................... 21
Incidentie dichtheid .......................................................................................................................... 22
Associatiematen ............................................................................................................................... 24
Risicoverschil (RV) ............................................................................................................................. 24
The Number Needed to Treat (NNT) ................................................................................................ 25
Relatief risico (RR) ............................................................................................................................. 25
Attributieve proportie van de blootgestelde populatie (APE) .......................................................... 26
Attributieve proportie van de totale populatie (APT) ....................................................................... 26
Odds ratio (OR) ................................................................................................................................. 26
(Correlatiematen (pearson r, ICC, Spearman rank)) ......................................................................... 27
College 4 MKNO .................................................................................................................................... 28
Externe validiteit ............................................................................................................................... 28
Interne validiteit ............................................................................................................................... 28
Betrouwbaarheid .............................................................................................................................. 28
Standaard fout .................................................................................................................................. 29
Betrouwbaarheidsinterval ................................................................................................................ 29
Grote en kleine precisie .................................................................................................................... 29
Validiteit van onderzoeksresultaten ................................................................................................. 29
Bias.................................................................................................................................................... 29
Response verhogen .......................................................................................................................... 30
Selectie bias = ................................................................................................................................... 30
Selectie bias: cohortonderzoek......................................................................................................... 31
Informatiebias................................................................................................................................... 31
Observer bias .................................................................................................................................... 31
Recall bias ......................................................................................................................................... 32
Confounding ..................................................................................................................................... 32
Verschil confounding en bias ............................................................................................................ 33
Elimineren van confounding ............................................................................................................. 34
Effect modificatie .............................................................................................................................. 34
Verschil effectmodificatie en confouding: ........................................................................................ 35
College 5 en 6 MKNO ............................................................................................................................ 36
Verschil interactie en effectmodificatie ............................................................................................ 36
Etiologisch onderzoek ....................................................................................................................... 37
3
, Aard onderzoeksbevindingen ........................................................................................................... 38
Causaliteit – Criteria van Hill ............................................................................................................. 38
Etiologisch onderzoek – designs ....................................................................................................... 38
Design van data-analyse bij etiologisch onderzoek ........................................................................ 39
Voorbeeld confounding case-control study...................................................................................... 40
College 7 en 8 MKNO ............................................................................................................................ 41
Interventie onderzoek ...................................................................................................................... 41
Klinisch epidemiologisch onderzoeksopzet ...................................................................................... 41
Interventieonderzoek (achtergrond) ................................................................................................ 41
Experimenteel vs. niet-experimenteel onderzoek ............................................................................ 42
Confounding interventie onderzoek ................................................................................................. 42
College 9 MKNO .................................................................................................................................... 43
Diagnostisch onderzoek .................................................................................................................... 43
Prognostisch onderzoek ................................................................................................................... 43
Diagnostisch versus Prognostische onderzoek ................................................................................. 43
Selectie bias ...................................................................................................................................... 44
Measurement bias ............................................................................................................................ 44
Attrition bias ..................................................................................................................................... 44
Vaststellen van het model ................................................................................................................ 45
College 11 en 12 MKNO ........................................................................................................................ 47
Klinimetrisch onderzoek ................................................................................................................... 47
Klinimetrisch versus Diagnostisch onderzoek ................................................................................... 47
Voorbeeld klinimetrisch onderzoek .................................................................................................. 48
Klinimetrisch onderzoek à theoretisch design ................................................................................ 48
Kwaliteit meetinstrumenten ............................................................................................................. 48
Vormen van validiteit........................................................................................................................ 48
Face validiteit: ................................................................................................................................... 49
Content validiteit: ............................................................................................................................. 49
Construct validiteit ........................................................................................................................... 49
Criterium validiteit ............................................................................................................................ 49
Vormen van betrouwbaarheid ......................................................................................................... 50
Betrouwbaarheid/interne consistentie ............................................................................................ 50
Responsitiviteit longitudinale validiteit .......................................................................................... 50
Klinische bruikbaarheid .................................................................................................................... 50
Klinimetrisch onderzoek – dataverzameling ..................................................................................... 51
Opzet klinimetrisch onderzoek KIPPI ................................................................................................ 51
4
The benefits of buying summaries with Stuvia:
Guaranteed quality through customer reviews
Stuvia customers have reviewed more than 700,000 summaries. This how you know that you are buying the best documents.
Quick and easy check-out
You can quickly pay through credit card or Stuvia-credit for the summaries. There is no membership needed.
Focus on what matters
Your fellow students write the study notes themselves, which is why the documents are always reliable and up-to-date. This ensures you quickly get to the core!
Frequently asked questions
What do I get when I buy this document?
You get a PDF, available immediately after your purchase. The purchased document is accessible anytime, anywhere and indefinitely through your profile.
Satisfaction guarantee: how does it work?
Our satisfaction guarantee ensures that you always find a study document that suits you well. You fill out a form, and our customer service team takes care of the rest.
Who am I buying these notes from?
Stuvia is a marketplace, so you are not buying this document from us, but from seller michelledanique1996. Stuvia facilitates payment to the seller.
Will I be stuck with a subscription?
No, you only buy these notes for $8.52. You're not tied to anything after your purchase.
